Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When you start semaglutide therapy, your body's chemistry shifts in measurable ways. While the medication itself does not appear as a detectable compound on standard blood panels, it actively changes the markers your doctor uses to assess your metabolic health and treatment response.
How Semaglutide Affects Blood Glucose and Insulin Levels
Semaglutide works by activating GLP-1 receptors in your pancreas, which triggers insulin release when blood sugar rises. This action lowers fasting glucose levels and reduces postprandial (after-meal) blood sugar spikes. Most patients experience measurable drops in fasting glucose within the first 2–4 weeks of treatment, and this change appears clearly on blood work.
Your hemoglobin A1C—a marker that reflects average blood sugar over three months—typically declines by 1–2 percentage points in the first three months of semaglutide use. This reduction demonstrates improved glucose control and is one of the most important metrics your doctor will track during your treatment journey. Regular blood work allows your prescriber to confirm the medication is working as intended and to adjust your dose if needed.
Lipid Panel Changes and What They Mean
Semaglutide also influences your lipid profile—the cholesterol and triglyceride markers on your blood work. Many patients see reductions in total cholesterol and LDL cholesterol, while some experience modest increases in HDL cholesterol. These changes reflect the medication's broader effect on your metabolic state, not a direct chemical detection of the drug itself.
Triglyceride levels often drop significantly because semaglutide reduces overall caloric intake and improves insulin sensitivity. If you have elevated triglycerides at baseline, your blood work may show improvement within 4–8 weeks. This metabolic shift is a positive sign that your body is responding to treatment, though your individual response depends partly on your genetic makeup—something PlexusDx's Precision Peptide Genetic Test can illuminate.
Liver and Kidney Function: What Blood Tests Reveal
Standard liver function tests (ALT, AST, alkaline phosphatase) and kidney function markers (creatinine, BUN) do not detect semaglutide directly. However, these tests remain important baseline measurements and follow-up checks because sustained weight loss and improved metabolic health can positively influence liver and kidney function over time. Your prescriber will typically order these tests before starting treatment and periodically during your therapy.
If you have nonalcoholic fatty liver disease (NAFLD) or mild kidney impairment, semaglutide may help improve these conditions through weight loss and glycemic control. Blood work documenting improvements in liver enzymes or stabilization of kidney markers can confirm that your overall health trajectory is moving in the right direction. This is why transparent communication with your healthcare provider about all blood work results is essential.
Will Your Doctor Know You Are Taking Semaglutide from Blood Work Alone?
No standard blood test directly identifies semaglutide or confirms its presence in your system. However, the metabolic fingerprint—lower fasting glucose, reduced A1C, improved lipid ratios, and weight loss—creates a clear clinical picture that experienced physicians recognize. Your doctor does not need a specific semaglutide detection test; the changes in your metabolic markers tell the story of your treatment response.
This is why disclosure remains important. If you are seeing multiple healthcare providers or specialists, tell each one that you are using semaglutide. Some medications interact with GLP-1 therapy, and certain medical conditions require dose adjustments or closer monitoring. PlexusDx ensures your prescriber has access to your complete health profile and genetic insights through the Precision Peptide Genetic Test, enabling truly personalized dosing that maximizes your results without unnecessary price increases as your therapeutic needs evolve.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can a blood test detect semaglutide directly?
No. Standard clinical laboratory tests cannot identify semaglutide as a chemical compound in your blood. Instead, doctors monitor your treatment by observing changes in glucose, lipids, and other metabolic markers that reflect how the medication is working in your body.
What blood work changes should I expect within the first month of semaglutide?
Fasting glucose typically begins dropping within 2–4 weeks, and some patients notice improvements in triglycerides. A complete picture emerges after 4–8 weeks, when hemoglobin A1C changes become measurable. Your PlexusDx prescriber will recommend testing intervals based on your baseline health and dose progression.
How much does PlexusDx semaglutide cost, and does pricing change as my dose increases?
PlexusDx Compounded Semaglutide Injection starts at $149 per month with a flat-rate pricing model—your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies, require no insurance, and qualify for HSA/FSA accounts.
Are there any blood work markers I should avoid or be concerned about during semaglutide therapy?
Semaglutide is well-tolerated, and blood work abnormalities are rare. Pancreatitis is a potential but uncommon side effect, so your doctor may monitor lipase or amylase if you experience severe abdominal pain. Always report unusual symptoms to your prescriber immediately.
How does PlexusDx's genetic test help me understand my semaglutide response?
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and FTO rs9939609. These insights help PlexusDx customize your dose and compound selection for optimal results—ensuring your blood work shows the improvements you deserve.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Drugs Should Not Be Taken With Ozempic? A Guide to Safe Medication Use
Recognizing Progress: How Do You Know When Ozempic Is Working?